Severe Ulcerative Perniosis Treated With Botulinum Toxin
146311463114631Botulinum ToxinPerniosis (also known as pernio or chilblains), is a condition characterized by the development of pruritic, painful erythrocyanotic skin lesions induced by exposure to cold temperatures.² When perniosis occurs in conjunction with clinical or laboratory features of systemic lupus erythematosus, the condition is further classified as chilblain lupus erythematosus (CHLE). CHLE is a rare condition w …
Botulinum Toxin
Botulinum Toxin in the Long-Term Treatment of Refractory Raynaud’s Phenomenon
145721457214572Refractory Raynaud’s PhenomenonRaynaud’s phenomenon is an exaggerated physiological response of blood vessels in the distal extremities to emotional stress and cold. It can be idiopathic or secondary to a connective tissue disorder, such as scleroderma or systemic lupus erythematosus. Treatment for Raynaud’s phenomenon consists primarily of lifestyle modifications; if unsuccessful, pharmacotherapy with dihydropyridine calci …
Refractory Raynaud’s Phenomenon
Infraorbital Occlusion Treated with High-Dose Pulsed Hyaluronidase Protocol
145171451714517Infraorbital OcclusionFacial fillers are an increasingly popular cosmetic procedure used for facial rejuvenation. Regardless of the experience and skill level of the injector, fillers can inadvertently occlude vessels leading to blockage of cutaneous blood supply, ischemic skin necrosis and rarely cerebrovascular strokes and blindness. Injectors should recognize early signs of occlusion and be prepared with knowledge a …
Infraorbital Occlusion
Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
142771427714277Palmoplantar PustulosisPalmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …
Palmoplantar Pustulosis
Pyoderma Gangrenosum Occurring in the Setting of Hypercortisolism
140021400214002Pyoderma GangrenosumPyoderma Gangrenosum Occurring in the Setting of Hypercortisolism Associated With Adrenocortical Adenoma: A Pathophysiological Paradox Pyoderma gangrenosum (PG) is a challenging, rare, ulcerating skin disease characterized by neutrophilic abundance and absence of infection, often associated with systemic diseases. JDD authors Chapman Wei, Elizabeth Hazuka, Peter DeRosa, Jill M. Paulson MD, and Ad …
Pyoderma Gangrenosum